Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

CS12192 effectively treats alopecia areata with better safety than current options.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Adding a second method to PROTACs could improve cancer treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib is effective and safe for treating severe alopecia areata.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tofacitinib, a hair regrowth treatment, may worsen acne.

TAK-279 effectively reduces psoriasis symptoms and is safe.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.